Gestational Hypertension
76
22
26
30
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
1.3%
1 terminated out of 76 trials
96.8%
+10.3% vs benchmark
14%
11 trials in Phase 3/4
20%
6 of 30 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 30 completed trials
Clinical Trials (76)
Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
Digital Solutions to Reduce Maternal Morbidity and Mortality in Pregnant Refugee Women
Vagal Stimulation Therapy and Preeclampsia
CONNEQT Pulse Validation Study
A Randomized, Placebo-controlled Trial of DAPAgliflozin (DAPA) for Cardiovascular Risk Reduction in the Postpartum Period of Hypertensive Pregnancies (HP)
MumCare: Mum's Cardiovascular Health for Life
Treatment With Aspirin After Preeclampsia: TAP Trial
LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia Prevention
Evaluation of sFlt-1/PlGF Ratio ,OPG and sEng as Predictive Biomarkers in the Diagnosis and Treatment Evaluation of Preeclampsia
Optimal Blood Pressure Treatment Thresholds Postpartum
Intervention for Fear of Childbirth in High-Risk Pregnant Women
Effect of Pilates Exercise Versus Circuit Exercise Training on Gestational Hypertension
The ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensive Therapy.
Peking University Birth Cohort in Weifang (PKUBC-WF)
Preventing Obstetric Complications With Dietary Intervention
Cardiovascular Protection After Preeclampsia With Enalapril
Spironolactone to Improve Pregnancy-Associated Hypertension Trajectories
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
AtorvaStatin Postpartum and Reduction of Cardiovascular risK
Nutrition Optimization and Community Upliftment for Postpartum Recovery: Hypertension